News
12 May 2026
Frost & Sullivan’s 2026 Global Company of the Year
Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.
7 January 2026
Avance Clinical Strengthens Global Oncology Offering with Acquisition of U.S-Based LumaBridge
Avance Clinical today announced the acquisition of LumaBridge, a specialized U.S.-based clinical CRO with deep expertise in oncology trials.
6 November 2025
Avance Clinical Launches Diversity in STEM Scholarships Across Australia and North America
Avance Clinical has announced the launch of its new Diversity in STEM Scholarships.
3 November 2025
Avance Clinical Showcases Early Phase Expertise and the Australian Advantage for EU Biotechs at BIO-Europe Vienna
Helping European Biotechs Accelerate Early Phase Success With Faster Timelines, Lower Costs, and Globally Accepted Data
30 October 2025
Avance Clinical Launches Renal and Cardiometabolic Center of Excellence to Optimize Patient Recruitment to Elevate Study Success
Avance Clinical, a partner for biotechs providing global contract research organization services, has announced the launch of the Renal & Cardiometabolic Center of Excellence.
28 October 2025
Avance Clinical Unveils Dedicated CNS Center of Excellence for Expert Clinical Trial Services in Neuroscience
Avance Clinical announced the launch of its Center of Excellence dedicated to central nervous system (CNS) disorders.
20 October 2025
Avance Clinical Launches Dedicated Center of Excellence to Accelerate Early Phase Biotech Trials
Avance Clinical today announced the launch of its dedicated Early Phase Center of Excellence for Biotechs
25 September 2025
Avance Clinical Strengthens Korea Focus: Seoul Meeting Highlights Growth, Partnerships, and Regional Collaboration
Avance Clinical, a global CRO headquartered in South Australia, met with Mr Jeff Robinson, South Australian Ambassador to Korea, to advance collaboration opportunities between South Australia and Korea in biotech clinical research.
9 September 2025
Avance Clinical Attends Reception Welcoming Australia’s US Ambassador to North Carolina Governor’s Executive Mansion in Raleigh, N.C.
On September 3, 2025, Avance Clinical was honored to attend a special reception at the Executive Mansion in Raleigh, North Carolina, hosted by Governor Josh Stein to welcome His Excellency, The Honorable Kevin Rudd AC, Australia’s Ambassador to the United States.
27 August 2025
Avance Clinical Accelerates Time to Pivotal Milestones for More Than 700 Emerging Biotechs
Avance Clinical has now guided 710 emerging biotechs through critical clinical trial inflection points.
6 June 2025
Avance Clinical Appoints Mark Harvill as Chief Executive Officer
Avance Clinical, a leading CRO for early-phase and Phase II biotech trials in Australia, the APAC region and the U.S., has appointed Mark Harvill as Chief Executive Officer.
28 May 2025
Australia Delivers Certainty for US Biotechs in 2025
As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable launchpad for early-phase clinical trials.
15 May 2025
Avance Clinical Honored with Frost & Sullivan’s 2025 Global Customer Value Leadership Award for Transformative Biotech CRO Services
This award recognizes Avance Clinical’s strategic innovation, operational agility, and unwavering commitment to client success in early-phase clinical trials.
Proven industry
experience & expertise
800+
Studies in the past 10 years
500+
Experienced team members
33k+
Participants past 10 years
30
Years of CRO experience